Skip to main content

Table 3 Observed and predicted 10-year overall survival from outcome calculator, stratified by patients’ characteristics

From: Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia

 

N

Observed death in 10 years

Predicted death in 10 years

Mortality Ratio (95 % CI)

Observed 10-year survival (%)(std err)

Predicted 10-year survival (median) (%)

Absolute difference (%) (95 % CI)

Overall

1649

488

454

1.07(0.98,1.17)

70.4 (0.011)

75.3

4.9 (2.7,7.1)

 Ethnicity

 Chinese

1201

318

318

1.00(0.89,1.12)

73.5 (0.013)

76.8

3.3 (0.8,5.8)

 Malay

251

100

74

1.35(1.10,1.64)

60.2 (0.031)

72.3

12.1(6.0,18.2)

 Indian

174

64

55

1.16(0.90,1.49)

63.2 (0.037)

69.9

6.7 (−0.6,14.0)

 Other

23

6

7

0.86(0.31,1.87)

73.9 (0.092)

77.1

3.2 (−14.8,21.2)

Country

 Malaysia

983

341

284

1.20(1.08,1.34)

65.3 (0.015)

73.3

8.0 (5.1,10.9)

 Singapore

666

147

170

0.86(0.73,1.02)

77.9 (0.016)

77.9

0.0 (−3.1,3.1)

Period of diagnosis

 1990–1994

140

56

42

1.33(1.01,1.73)

60.0 (0.041)

72.5

12.5(4.5,20.5)

 1995–1999

564

187

148

1.26(1.09,1.46)

66.8 (0.020)

76.0

9.2 (5.3,13.1)

 2000–2002

945

245

264

0.93(0.82,1.05)

74.1 (0.014)

75.9

1.8 (−0.9,4.5)

Age at diagnosis

 0–39

232

82

58

1.41(1.12,1.75)

64.7 (0.031)

77.3

12.6 (6.5,18.7)

 40–49

576

137

130

1.05(0.88,1.25)

76.2 (0.018)

80.2

4.0 (0.5,7.5)

 50–59

493

141

129

1.09(0.92,1.29)

71.4 (0.020)

76.4

5.0 (1.1,8.9)

 60–69

254

78

86

0.91(0.72,1.13)

69.3 (0.029)

68.4

−0.9 (−6.6,4.8)

 70+

94

50

50

1.00(0.74,1.32)

46.8 (0.051)

50.1

3.3 (−6.7,13.3)

Tumor size (mm)

 0–20

653

118

109

1.08(0.90,1.30)

81.9 (0.015)

86.8

4.9 (2.0,7.8)

 21–50

831

283

262

1.08(0.96,1.21)

65.9 (0.016)

70.6

4.7 (1.6,7.8)

 51+

165

87

82

1.06(0.85,1.31)

47.3 (0.039)

50.6

3.3 (–4.3,10.9)

Number of positive nodes

 0

867

147

161

0.91(0.77,1.07)

83.0 (0.013)

84.0

1.0 (−1.5,3.5)

 1–3

407

143

120

1.19(1.00,1.40)

64.9 (0.024)

72.1

7.2 (2.5,11.9)

 4–9

215

112

93

1.20(0.99,1.45)

47.9 (0.034)

58.2

10.3 (3.6,17.0)

 10+

104

71

62

1.15(0.89,1.44)

31.7 (0.046)

39.9

8.2 (−0.8,17.2)

 Unknown

56

15

17

0.88(0.49,1.46)

73.2 (0.059)

73.5

0.3 (−11.3,11.9)

ER status

 Negative

637

224

197

1.14(0.99,1.30)

64.8 (0.019)

71.5

6.7 (3.0,10.4)

 Positive

816

205

206

1.00(0.86,1.14)

74.9 (0.015)

78.2

3.3 (0.4,6.2)

 Unknown

196

59

51

1.16(0.88,1.49)

69.9 (0.033)

76.8

6.9 (0.4,13.4)

PR status

 Negative

485

160

153

1.05(0.89,1.22)

67.0 (0.021)

70.7

3.7(−0.4,7.8)

 Positive

564

128

136

0.94(0.79,1.12)

77.3 (0.018)

79.9

2.6 (−0.9,6.1)

 Unknown

600

200

165

1.21(1.05,1.39)

66.7 (0.019)

74.1

7.4 (3.7,11.1)

Her2 status

 Negative

269

72

66

1.09(0.85,1.37)

73.2 (0.027)

78.3

5.1(−0.2,10.4)

 Equivocal

13

6

4

1.50(0.55,3.26)

53.8 (0.138)

65.5

11.7 (−15.3,38.7)

 Positive

335

113

110

1.03(0.85,1.24)

66.3 (0.026)

69.1

2.8 (−2.3,7.9)

 Unknown

1032

297

273

1.09(0.97,1.22)

71.2 (0.014)

76.8

5.6 (2.9,8.3)

Histology

 Ductal

1418

445

401

1.11(1.01,1.22)

68.6 (0.012)

74.4

5.8 (3.4,8.2)

 Lobular

78

18

21

0.86(0.51,1.35)

76.9 (0.048)

75.7

−1.2 (−10.6,8.2)

 Mucinous

59

9

9

1.00(0.46,1.90)

84.7 (0.047)

91.2

6.5 (−2.7,15.7)

 Others

91

16

22

0.73(0.42,1.18)

82.4 (0.040)

77.7

−4.7 (−12.5,3.1)

 Unknown

3

0

1

-

100

74.4

−25.6

Grade

 1

200

22

31

0.71(0.44,1.07)

89.0 (0.022)

89.3

0.3 (−4.0,4.6)

 2

668

188

176

1.07(0.92,1.23)

71.9 (0.017)

77.1

5.2 (1.9, 8.5)

 3

510

196

172

1.14(0.99,1.31)

61.6 (0.022)

70.0

8.4 (4.1,12.7)

 Unknown

271

82

76

1.08(0.86,1.34)

69.7 (0.028)

73.3

3.6 (−1.9,9.1)

  1. Numbers marked in bold indicate statistically significant difference at the 95% confidence level